Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: J Psychiatr Pract. 2016 May;22(3):175–182. doi: 10.1097/PRA.0000000000000149

TABLE 1.

Demographic and Clinical Characteristics of the Sample by Lithium/Valproate Status

n (%) t/χ2 P
No Lithium/Valproate (N=72) Lithium/Valproate (N=19)
Age (Mean±SD) 43.39±10.60 42.39±8.49 0.37 0.713
Sex: male 55 (76.4) 13 (68.4) 0.51 0.477
Race: white 56 (77.8) 15 (79.0) 0.01 0.913
Diagnosis: schizophrenia 58 (80.6) 11 (57.9) 4.21 0.040
Study
 Insulin secretion 52 (72.2) 1 (5.3) 27.71 0.000
 Aripiprazole 12 (16.7) 12 (63.2) 16.73 0.000
 Rosiglitazone 8 (11.1) 6 (31.6) 4.84 0.028
Medication*
 Olanzapine, clozapine 52 (72.2) 19 (100.0) 6.76 0.009
 Risperidone, quetiapine 23 (31.9) 4 (21.1) 0.85 0.355
*

Seven participants were prescribed >1 type of antipsychotic, so that the proportion does not sum to 100%.